You're a seasoned health economics and outcomes research professional with at least a decade of experience, likely holding an MD, PhD, or PharmD, and a strong b
Work type: hybrid
Location: Redwood City, California, United States
Salary: $244,000 – $305,000/yr
Type: Full-time
You're a seasoned health economics and outcomes research professional with at least a decade of experience, likely holding an MD, PhD, or PharmD, and a strong background in oncology HEOR and real-world evidence development. **What makes it worth a look...** Revolution Medicines is offering a full-time, hybrid role in Redwood City, California, with a substantial annual salary of USD 244,000 - 305,000. **You might be a good fit if you...** * Have deep expertise in health economics, outcomes research, or patient-reported outcomes within biotech or pharma. * Possess a proven track record of high-impact publications in HEOR/RWE topics. * Understand managed care, formulary decision-making, and payment/access models. * Can establish relationships with experts in real-world evidence and relevant therapeutic areas.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Director, HEOR/RWE is responsible for providing input on the strategy and executing HEOR plans and activities related to all Revolution Medicines assets intended for use in non-small cell lung cancer (NSCLC). They will be accountable for demonstrating the value of Revolution Medicines products to healthcare organizations, allowing them to make informed decisions. They will work closely with the Medical Affairs team as well as other cross-functional teams to optimize the Integrated Evidence Plan (IEP) and to deliver evidence supporting the use of Revolution Medicines products. The candidate must also be able to provide input and strategic guidance on the global value of the product as well as have demonstrated success in evidence generation globally. The Senior Director HEOR/RWE will participate with the matrix team across the function to ensure alignment of all activities with the strategic and tactical plans. This is an exceptional opportunity to contribute to the advancement of healthcare by providing evidence that can shape the future of patient care in oncology.
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.